NYSEARCA:BIV Vanguard Intermediate-Term Bond ETF (BIV) Price, Holdings, & News → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free BIV Stock Alerts $73.34 +0.16 (+0.22%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$73.30▼$73.4450-Day Range$73.13▼$75.6852-Week Range$70.43▼$77.68Volume639,499 shsAverage Volume1.29 million shsMarket Capitalization$17.02 billionAssets Under Management$17.19 billionDividend Yield2.44%Net Expense Ratio0.04% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOwnershipStock AnalysisChartDividendHeadlinesHoldingsOwnership Get Vanguard Intermediate-Term Bond ETF alerts: Email Address About Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIV)Vanguard Intermediate-Term Bond ETF (the Fund) seeks to track the performance of a market-weighted bond index with an intermediate-term, dollar-weighted average maturity. The Fund employs a passive management or indexing strategy designed to track the performance of the Barclays Capital U.S. 5-10 Year Government/Credit Bond Index (the Index). The Index includes all medium and larger issues of the United States Government, investment-grade corporate, and investment-grade international dollar-denominated bonds that have maturities between 5 and 10 years and are publicly issued. The Fund invests by sampling the Index, meaning that it holds a range of securities that, in the aggregate, approximate the full Index in terms of key risk factors and other characteristics. All of the Fund’s investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the Index. The Fund’s investment advisor is The Vanguard Group, Inc.Read More BIV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIV ETF News HeadlinesApril 9, 2024 | morningstar.comThe Best Bond Index Funds: Part 1March 1, 2024 | seekingalpha.comFirst Look At The Vanguard Core Bond ETFApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 1, 2024 | seekingalpha.comVTEI Vanguard Intermediate-Term Tax-Exempt Bond ETFFebruary 29, 2024 | msn.comVanguard Intermediate-Term Bond ETF declares monthly distribution of $0.2114February 22, 2024 | msn.comETF Edge: The rise of intermediate term bondsFebruary 9, 2024 | seekingalpha.comBIV: Why The ETF Is A Good InvestmentJanuary 10, 2024 | bloomberg.comVanguard, Pimco Bet on Energy to Fan Blue-Chip Bond Fund RalliesApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.November 30, 2023 | msn.comVanguard Intermediate-Term Bond ETF declares monthly distribution of $0.2127See More Headlines Receive BIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vanguard Intermediate-Term Bond ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVanguard Fund NameVanguard Intermediate-Term Bond ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BIV Inception Date4/3/2007 Fund ManagerJoshua C. Barrickman Webwww.vanguard.com Phone+1-800-6627447Fund Focus Asset ClassFixed Income BenchmarkBloomberg U.S. 5-10 Year Government/Credit Float Adjusted Index CategoryBroad Debt FocusInvestment Grade Development LevelDeveloped Markets RegionNorth America Number of Holdings2239 Fund Statistics Assets Under Management$17.19 billion Average Daily Volume$1.10 million Discount/Premium0.08% Administrator, Advisor and Custodian AdministratorThe Vanguard Group, Inc. AdvisorThe Vanguard Group, Inc. CustodianJPMorgan Chase Bank, N.A. DistributorVanguard Marketing Corporation Transfer AgentThe Vanguard Group, Inc. TrusteeN/A Lead Market MakerSusquehanna Options OptionableN/A Short Interest126,900 shs Miscellaneous Outstanding Shares232,050,000Beta0.13 Creation Unit100,000 Creation Fee$100.00 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Vanguard Intermediate-Term Bond ETF ExpensesTypeBIVInvestment Grade ETFsFixed Income ETFsNYSEARCA ETFsAll ETFsManagement Fee0.03%0.22%0.32%0.50%0.51%Other Expenses0.01%0.12%0.27%0.64%0.58%Total Expense0.04%0.25%0.40%0.74%0.70%Fee Waiver0.00%-0.15%-0.24%-0.68%-0.57%Net Expense0.04%0.22%0.35%0.58%0.58% Vanguard Intermediate-Term Bond ETF (BIV) Holdings & ExposureTop 10 BIV HoldingsUnited States Treasury NotesHolding Weight: 2.30%United States Treasury NotesHolding Weight: 2.28%United States Treasury NotesHolding Weight: 2.13%United States Treasury NotesHolding Weight: 2.03%United States Treasury NotesHolding Weight: 2.01%United States Treasury NotesHolding Weight: 1.99%United States Treasury NotesHolding Weight: 1.99%United States Treasury NotesHolding Weight: 1.96%United States Treasury NotesHolding Weight: 1.93%United States Treasury NotesHolding Weight: 1.92%BIV Sector ExposureBIV Industry ExposureFull Holdings Details Key ExecutivesF. William McNabb III (Age 61)Chairman of the Board of Trustees, President, Chief Executive Officer Thomas J. Higgins (Age 56)Chief Financial Officer Kathryn J. Hyatt (Age 58)Treasurer Heidi Stam (Age 57)Secretary Emerson U. Fullwood (Age 69)Independent Trustee Rajiv L. Gupta (Age 71)Independent Trustee Amy Gutmann (Age 64)Independent Trustee JoAnn H Heisen (Age 63)Independent Trustee F. Joseph Loughrey (Age 69)Independent Trustee More ExecutivesSimilar ETFsiShares 1-5 Year Investment Grade Corporate Bond ETFNASDAQ:IGSBiShares 5-10 Year Investment Grade Corporate Bond ETFNASDAQ:IGIBPIMCO Enhanced Short Maturity Exchange-Traded FundNYSEARCA:MINTJPMorgan Ultra-Short Income ETFNYSEARCA:JPSTiShares Broad USD Investment Grade Corporate Bond ETFNASDAQ:USIGInstitutional OwnershipAustin Asset Management Co IncBought 5,618 shares on 4/27/2024Ownership: 0.054%Fonville Wealth Management LLCBought 15,534 shares on 4/27/2024Ownership: 0.022%Capital Performance Advisors LLPBought 24,333 shares on 4/27/2024Ownership: 0.021%Verdence Capital Advisors LLCSold 257 shares on 4/26/2024Ownership: 0.004%Prestige Wealth Management Group LLCBought 404 shares on 4/26/2024Ownership: 0.001%View All Institutional Transactions BIV ETF - Frequently Asked Questions How have BIV shares performed in 2024? Vanguard Intermediate-Term Bond ETF's stock was trading at $76.38 at the beginning of the year. Since then, BIV shares have decreased by 4.0% and is now trading at $73.34. View the best growth stocks for 2024 here. How often does Vanguard Intermediate-Term Bond ETF pay dividends? What is the dividend yield for Vanguard Intermediate-Term Bond ETF? Vanguard Intermediate-Term Bond ETF declared a dividend on Wednesday, January 17th. Investors of record on Tuesday, April 2nd will be paid a dividend of $0.2337 per share on Thursday, April 4th. The ex-dividend date is Monday, April 1st. This is a boost from the stock's previous dividend of $0.22. Read our dividend analysis for BIV. What does BIV invest in? Vanguard Intermediate-Term Bond ETF is a fixed income fund issued by Vanguard. BIV focuses on investment grade investments and follows the Bloomberg U.S. 5-10 Year Government/Credit Float Adjusted Index. The fund's investments total to approximately $17.19 billion assets under management. What is the management fee for Vanguard Intermediate-Term Bond ETF? Vanguard Intermediate-Term Bond ETF's management fee is 0.03% and has other expenses of 0.01%. The net expense ratio for BIV is 0.04%. What other stocks do shareholders of Vanguard Intermediate-Term Bond ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vanguard Intermediate-Term Bond ETF investors own include Alphabet (GOOG), Intel (INTC), Verizon Communications (VZ), Abbott Laboratories (ABT), Cisco Systems (CSCO), CVS Health (CVS), Walt Disney (DIS), Home Depot (HD), Johnson & Johnson (JNJ) and Walmart (WMT). Who are Vanguard Intermediate-Term Bond ETF's major shareholders? Vanguard Intermediate-Term Bond ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include True Link Financial Advisors LLC (1.16%), Mather Group LLC. (1.29%), Wealth Enhancement Advisory Services LLC (0.42%), Cambridge Investment Research Advisors Inc. (0.41%), BCM Advisors LLC (0.33%) and Raymond James Financial Services Advisors Inc. (0.29%). How do I buy shares of Vanguard Intermediate-Term Bond ETF? Shares of BIV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:BIV) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe World's First "$20 Trillion Drug?"Behind the MarketsMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vanguard Intermediate-Term Bond ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.